Superior Performance, Reliable Results.

Detect known and novel fusions with Fusions, a partner-agnostic FFPE RNA-based multiplex amplicon assay.

Canexia Health’s Fusions panel is designed to target a set of 17 genes and 59 exons that are key in diagnosis, prognosis, and approved therapeutic options in solid adult tumors.

GeneExon
ALK2, 10, 16-22
BRAF2, 6-12,15,19
CSF16-8
EGFR1-3, 7-9,11, 13,16, 20-21, 24-25, 27, 8, 23
ERG2-11
FGFR11-10, 14,17
FGFR22, 8-10,13, 16-17
FGFR32-4, 8-10, 16-18
MET2-6, 13-17, 21
NRG11, 1-8
NTRK12, 7-13
NTRK210-17
NTRK37, 12-18
PDGFB2
PPARG2, 7
RAF12, 8-10
RET2-4, 7-13
ROS131-37
Genes18
Exons150
Turnaround time3 to 5 days
Sensitivity95%
Specificity100%
Reproducibility100% (same input replicates), 91.67% (including replicates with different input

Benefits

Actionable Results

A targeted set of 17 genes and 59 exons that are key in diagnosis, prognosis, and approved therapeutic options in solid adult tumors.

Rapid Turnaround Time

A simple laboratory workflow that provides rapid, reliable, results.

Comprehensive Reports

Review detailed interpretations, current treatment options, and available clinical trials.

Cost-Effective

Targeted amplicon-based technology provides an economical alternative to single-gene testing or hybrid capture NGS assays.

Conserve Biopsy Tissue

Canexia Health Fusions assay allows for simultaneous hotspot testing, reducing the amount of biopsy tissue required, when compared to single-gene testing.

Accreditation

All Canexia Health assays and software are developed in our CLIA, CAP, CDPH and DAP accredited laboratory.

View Other Solutions

Plasma (Follow It®)

Canexia Health’s Follow It panel detects mutations in plasma. Plasma profiling (a type of liquid biopsy) can be used to help tailor treatment, monitor cancer progression, or detect treatment resistance.

Learn About Follow It

Tissue

Canexia Health’s Find It & Fusions panels detect mutations and gene fusion events in solid tumor tissue. Tissue profiling can be used to help inform treatment decisions or predict progression of cancer based on somatic mutations found in the tumor.

Learn About Tissue Assays

Canexia Health Insights Platform

Each comprehensive report includes detailed results as well as therapeutic recommendations and expertly curated clinical trials. Our insights can help make more informed treatment decisions.

Learn About Our Reports

Your Information On Your Servers

Perform world-leading mutation assays, right from your laboratory: Canexia Health’s proprietary bioinformatics platform covers everything from mutation identification to auto-generated clinical reports.

Learn More

Do More From Your Own Lab

Canexia Health’s expert and cost-effective assays, informatics, and support mean rapid assay results. Learn how partnering with Canexia can help you bring precision oncology in-house.

Get Started Today